Windtree Therapeutics might be delisted from the Nasdaq Capital Market after failing to fulfill itemizing necessities, a call that triggered an enormous sell-off in its inventory.
Windtree Faces Nasdaq Delisting Over Inventory Worth, Plans Transfer to OTC Markets
The SEC doc confirmed that Nasdaq notified the agency on August 19, 2025. Buying and selling on its shares can be suspended on the open market on August 21.
Windtree stated it expects its shares to proceed buying and selling publicly underneath the ticker WINT on OTC markets. The corporate has utilized to be quoted on the OTCID tier. Nonetheless, this isn’t assured.
Assuming that request is accepted, OTC buying and selling have decrease liquidity, visibility, and entry to buyers than the Nasdaq. Due to this fact, this casts doubts on the way forward for the corporate to boost capital.
The delisting is because of Windtree not having the ability to adjust to Nasdaq Itemizing Rule 5550(a) (2). This mandates a minimal bid worth of a minimum of one greenback per share. The corporate had already disclosed its noncompliance however failed to revive its inventory above the required threshold in time. Due to this fact, Nasdaq’s resolution displays each regulatory requirements and market actuality.
Chief government Jed Latkin signed the SEC submitting confirming the corporate’s stance. He emphasised that Windtree’s operations stay intact and that the agency will proceed assembly all reporting obligations with the Securities and Change Fee.
Final month, Windtree drew consideration past biotech circles when it adopted a Binance Coin (BNB) company treasury. That uncommon transfer echoed methods by corporations that maintain Bitcoin as a part of their stability sheets. It additionally positioned Windtree as one of many few public healthcare corporations linking biotech funding with cryptocurrency publicity.
Windtree Shares Collapse and BNB Rally Highlights Stark Divergence
The announcement instantly rattled buyers. Windtree’s shares collapsed by greater than 76% in a single day, falling from a earlier shut of $0.48 to only $0.11. TradingView information exhibits the inventory has now misplaced greater than 90% in a single month and over 99% yr so far. The plunge illustrates the depth of investor concern as the corporate prepares to transition away from a serious change into the over-the-counter market.
In the meantime, the announcement hasn’t affected BNB worth. The token climbed previous $850, gaining greater than 3% in 24 hours. TradingView information exhibits BNB closing at $852.14, extending its sturdy 2025 efficiency. The token is up over 12% this month, 30% in six months, and greater than 52% over the previous yr.
Paul
Paul Adedoyin is a crypto journalist with 4+ years expertise who offers well timed information, in-depth analysis, and insightful content material to tell and empower his viewers. His works have been featured on websites corresponding to CryptoMode, CryptoNewsFlash amongst others.
He holds a level in Geophysics from OAU, Nigeria. When he isn’t writing, he loves watching soccer and studying educative journals.
He might be reached through [email protected]
Funding disclaimer: The content material displays the creator’s private views and present market situations. Please conduct your individual analysis earlier than investing in cryptocurrencies, as neither the creator nor the publication is liable for any monetary losses.
Advert Disclosure: This web site could characteristic sponsored content material and affiliate hyperlinks. All ads are clearly labeled, and advert companions don’t have any affect over our editorial content material.
✓ Share: